{"generic":"Spinosad","drugs":["Natroba","Spinosad"],"mono":{"0":{"id":"929786-s-0","title":"Generic Names","mono":"Spinosad"},"1":{"id":"929786-s-1","title":"Dosing and Indications","sub":{"0":{"id":"929786-s-1-4","title":"Adult Dosing","mono":"<b>Pediculosis capitis:<\/b> Apply enough suspension to cover dry scalp, then apply to dry hair; leave on for 10 minutes; rinse off thoroughly with warm water; repeat application if live lice are present 7 days after initial treatment "},"1":{"id":"929786-s-1-5","title":"Pediatric Dosing","mono":"<b>Pediculosis capitis:<\/b> (6 months or older) Apply enough suspension to cover dry scalp, then apply to dry hair; leave on for 10 minutes; rinse off thoroughly with warm water; repeat application if live lice are present 7 days after initial treatment "},"3":{"id":"929786-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Pediculosis capitis<br\/>"}}},"3":{"id":"929786-s-3","title":"Contraindications\/Warnings","sub":[{"id":"929786-s-3-9","title":"Contraindications","mono":"specific contraindications have not been determined <br\/>"},{"id":"929786-s-3-10","title":"Precautions","mono":"<ul><li>benzyl alcohol toxicity may occur, especially in infants younger than 6 months due to increased absorption; use not recommended in infants younger than 6 months<\/li><li>report suspected adverse reactions to ParaPRO, LLC at 1-855-628-7622 or the US Food and Drug Administration at 1-800-FDA-1088 or www.fda.gov\/medwatch<\/li><\/ul>"},{"id":"929786-s-3-11","title":"Pregnancy Category","mono":"B (FDA)<br\/>"},{"id":"929786-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"929786-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Dermatologic:<\/b>Application site erythema (3%)<\/li><li><b>Ophthalmic:<\/b>Erythema, Ocular (2%)<\/li><\/ul>"},"6":{"id":"929786-s-6","title":"Drug Name Info","sub":{"0":{"id":"929786-s-6-17","title":"US Trade Names","mono":"Natroba<br\/>"},"2":{"id":"929786-s-6-19","title":"Class","mono":"Pediculicide<br\/>"},"3":{"id":"929786-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"929786-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"7":{"id":"929786-s-7","title":"Mechanism Of Action","mono":"Spinosad causes neuronal excitation in insects, and in lice, periods of hyperexcitation are followed by paralysis and death. Spinosad is derived from the fermentation of a soil actinomycete bacterium, Saccharopolyspora spinosa. Spinosad topical suspension is a mixture of spinosyn A and spinosyn D in a 5:1 ratio.<br\/>"},"9":{"id":"929786-s-9","title":"Administration","mono":"<ul><li><b>General Information<\/b><br\/>Not for oral, ophthalmic, or intravaginal use<br\/><\/li><li><b>Topical<\/b><br\/><ul><li>Avoid contact with eyes<\/li><li>Shake bottle well immediately prior to use<\/li><li>Apply enough suspension (up to 120 mL) to cover dry scalp, then apply to dry hair<\/li><li>Leave on for 10 minutes, then rinse off thoroughly with warm water<\/li><li>Repeat application if live lice are present 7 days after initial treatment<\/li><\/ul><\/li><\/ul>"},"10":{"id":"929786-s-10","title":"Monitoring","mono":"eradication of head lice infestation is indicative of efficacy <br\/>"},"11":{"id":"929786-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/>Topical Suspension: 0.9 %<br\/><\/li><li><b>Natroba<\/b><br\/>Topical Suspension: 0.9 %<br\/><\/li><\/ul>"},"13":{"id":"929786-s-13","title":"Clinical Teaching","mono":"<ul><li>Drug may cause application site reactions (erythema, irritation, dryness, or exfoliation), ocular erythema, and alopecia.<\/li><li>Instruct patient to contact physician if live lice are detected 7 days after initial application. A second application may be needed.<\/li><\/ul>"}}}